• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

For Industry

  • Print
  • Share
  • E-mail

Generic Drug Regulatory Science Initiatives Public Meeting: June 21, 2013

The Food and Drug Administration (FDA or the Agency) has scheduled a public meeting on June 21, 2013 to discuss generic drug regulatory science initiatives designed to promote the public health and advance innovation in regulatory decision-making.  The meeting will provide a forum for public discussion of Agency generic drug research priorities and an overview of current efforts.  FDA is seeking input from a variety of stakeholders––industry, academia, patient advocates, professional societies, and others as it develops its annual FY 2014 regulatory science plan.   Additional information on the public meeting is available at:  http://www.gpo.gov/fdsys/pkg/FR-2013-05-09/pdf/2013-11007.pdf.